Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 68462-393
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 68462-393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Total Hip Mean Percentage Change From Baseline: All Placebo And Raloxifene Hydrochloride Subjects 24 Months Data From Studies Na And Eu (Image 02)
Total Hip Mean Percentage Change From Baseline (All placebo, Raloxifene Hydrochloride and CE subjects 24-month data from Study INT (hysterectomized women))
Image 04
Image 06
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.